Please assess the completion status of the following clinical trial:

Trial Title: Thyroid Hormone Dose Adjustment in Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* women with a prior diagnosis of hypothyroidism, currently receiving levothyroxine therapy~* less than 8 weeks pregnant~Exclusion Criteria:~* cardiac disease, renal failure~* not euthyroid biochemically within 6 months pre-pregnancy

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 2 tablet increase (Type: ACTIVE_COMPARATOR): Patients will increase their current levothyroxine dose by 2 extra tablets per week (\~29% increase)
- 3 tablet increase (Type: ACTIVE_COMPARATOR): Patients will increase their levothyroxine dosage by 3 extra tablets per week (\~43%).

Based on this trial design, predict the completion outcome and termination type (if applicable).